Nicotine-like products expose blind spot in e-cigarette rules

A new regulatory gap has emerged concerning nicotine-free and nicotine-imitation products, following a recent law revision that introduced e-cigarettes to government regulation for the very first time. The law aimed to verify the safety of nicotine-imitation substances; however, actual nicotine has been found in some products that were marketed as nicotine-free, sparking a demand for a thorough system to control such items.

In April, the Tobacco Business Act underwent a revision which broadened the legal definition of tobacco to encompass both natural and synthetic nicotine. Due to this revision, using e-cigarettes is now prohibited in various places including schools, hospitals, government offices, and specific outdoor areas designated as non-smoking zones.

The sale of e-cigarettes through online platforms is also banned, and health warnings, including nicotine content and ingredient listings, must be displayed on product packaging. The sale of e-cigarettes to underage individuals is strictly forbidden, as are any promotional activities aimed at minors. Nevertheless, the Tobacco Business Act defines tobacco solely as products derived from tobacco leaves or nicotine, leaving products that mimic nicotine but do not contain it in a regulatory blind spot.